A Start-Up Claimed Its Device Could Cure Cancer. Then Patients Began Dying. ![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uZdzFu2-c8LNa3ZtHz6bxPZLzrT-Xfm6tlBPKTOmfPWqwxrRgHJrD5TJp_fhEnhM8EZdAtdmlFhCOxe8K2dsPVrdbKF6jjLdCxJBwv5R3Q00lPujf4nEiqa4B77bOEbD159kL2HZqovBh18AHvhmgU-k67u0JEYvAZCiIQJ8zmfGcBQ_cgVs2__GY=s0-d)
By John Carreyrou from NYT Business Day https://ift.tt/a8T0WXb
Cancer, Regulation and Deregulation of Industry, Blood, Food and Drug Administration, Antigua and Barbuda, Florida, Medical Devices, Tumors, Heparin (Drug), Deaths (Fatalities)
By John Carreyrou from NYT Business Day https://ift.tt/a8T0WXb
Cancer, Regulation and Deregulation of Industry, Blood, Food and Drug Administration, Antigua and Barbuda, Florida, Medical Devices, Tumors, Heparin (Drug), Deaths (Fatalities)
Comments
Post a Comment